BECLOMETASONE/FORMOTEROL ZENTIVA 200/6 micrograms/dose, solution for inhalation in a pressurised container 120 doses
Active ingredients: DIPROPIONATE DE BÉCLOMÉTASONE, Formoterol fumarate dihydrate
Commercialized according to BDPMDispensing in France: Prescription only
Solution for inhalation120 dosesinhalée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- BECLOMETASONE/FORMOTEROL ZENTIVA 200/6 microgrammes/dose, solution pour inhalation en flacon pressurisé
- Pharmaceutical form
- solution pour inhalation
- Route of administration
- inhalée
- Presentation description
- 1 flacon pressurisé aluminium de 120 doses avec valve doseuse dans inhalateur en plastique polypropylène avec compteur de doses avec embout buccal
- Marketing authorisation holder
- ZENTIVA FRANCE
- Reimbursement according to BDPM
- 65 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 23 Jan 2026
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63646148CIP73031850CIP133400930318508Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| DIPROPIONATE DE BÉCLOMÉTASONEsolution | 200 microgrammes · une dose mesurée | SA |
| FUMARATE DE FORMOTÉROL DIHYDRATÉsolution | 6 microgrammes · une dose délivrée | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.